Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2

De la Guardia, Carolina; Stephens, David E.; Dang, Hang T.; Quijada, Mario; Larionov, Oleg V.; Lleonart, Ricardo

doi:10.3390/molecules23030672

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessCommunication

Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2

Carolina De la Guardia

^1,2

¹,

³ and

^1,*

Institute of Scientific Research and High Technology Services (INDICASAT AIP), PO 0843-01103 City of Panama, Panama

Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, Andhra Pradesh, India

Department of Chemistry, University of Texas at San Antonio, San Antonio, TX 78249, USA

Author to whom correspondence should be addressed.

Molecules 2018, 23(3), 672; https://doi.org/10.3390/molecules23030672

Received: 19 February 2018 / Revised: 13 March 2018 / Accepted: 15 March 2018 / Published: 16 March 2018

(This article belongs to the Section Chemical Biology)

View Full-Text Download PDF

Browse Figures

Citation Export

Abstract

Dengue virus causes dengue fever, a debilitating disease with an increasing incidence in many tropical and subtropical territories. So far, there are no effective antivirals licensed to treat this virus. Here we describe the synthesis and antiviral activity evaluation of two compounds based on the quinoline scaffold, which has shown potential for the development of molecules with various biological activities. Two of the tested compounds showed dose-dependent inhibition of dengue virus serotype 2 in the low and sub micromolar range. The compounds 1 and 2 were also able to impair the accumulation of the viral envelope glycoprotein in infected cells, while showing no sign of direct virucidal activity and acting possibly through a mechanism involving the early stages of the infection. The results are congruent with previously reported data showing the potential of quinoline derivatives as a promising scaffold for the development of new antivirals against this important virus. View Full-Text

Keywords: dengue virus; quinolines; antiviral

▼ Show Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

Supplementary File 1:
PDF-Document (PDF, 619 KiB)

Share and Cite

MDPI and ACS Style

De la Guardia, C.; Stephens, D.E.; Dang, H.T.; Quijada, M.; Larionov, O.V.; Lleonart, R. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules 2018, 23, 672. https://doi.org/10.3390/molecules23030672

AMA Style

De la Guardia C, Stephens DE, Dang HT, Quijada M, Larionov OV, Lleonart R. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules. 2018; 23(3):672. https://doi.org/10.3390/molecules23030672

Chicago/Turabian Style

De la Guardia, Carolina, David E. Stephens, Hang T. Dang, Mario Quijada, Oleg V. Larionov, and Ricardo Lleonart. 2018. "Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2" Molecules 23, no. 3: 672. https://doi.org/10.3390/molecules23030672

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2

Abstract

Supplementary Material

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI